About remibrutinib
Bruton tyrosine kinase inhibitor
Used for
- Treatment of chronic spontaneous urticaria in adults who remain symptomatic despite H1 antihistamines.
Usual adult dose
25 mg by mouth twice daily.
Common side effects
- Headache
- Nausea
- Abdominal pain
- Diarrhea
Important warnings
- May increase bleeding risk, especially with blood thinners.
- Report signs of infection; serious infections may occur.
- Avoid live vaccines during treatment.
- Liver injury has been reported; monitoring may be needed.
Pregnancy
Human pregnancy data are limited; potential fetal harm is unknown.
Breastfeeding
It is unknown whether remibrutinib passes into breast milk; breastfeeding effects are uncertain.
Interactions
- Strong or moderate CYP3A inhibitors may increase drug levels.
- Strong or moderate CYP3A inducers may reduce drug levels.
- May increase bleeding risk with anticoagulants or antiplatelet medicines.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.